CareDx, Inc. (CDNA) is a publicly traded Healthcare sector company. As of October 19, 2026, CDNA trades at $63.63 with a market cap of $3.31B and a P/E ratio of 30.92. CDNA moved -3.98% today. Year to date, CDNA is +239.70%; over the trailing twelve months it is +326.95%. Its 52-week range spans $10.96 to $72.51. Analyst consensus is buy with an average price target of $54.00. Rallies surfaces CDNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CDNA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $63.63 |
| Market Cap | $3.31B |
| P/E Ratio | 30.92 |
| EPS | $2.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $72.51 |
| 52-Week Low | $10.96 |
| Volume | 1.23M |
| Avg Volume | 0 |
| Revenue (TTM) | $458.09M |
| Net Income | $111.01M |
| Gross Margin | 0.00% |
6 analysts cover CDNA: 0 strong buy, 3 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $54.00.